Table 1.
Correlation of FMNL2 and CTTN expressions with clinicopathological characteristics of patients with GBAC
| Variable | FMNL2 | P | CTTN | P | ||
|---|---|---|---|---|---|---|
|
|
|
|||||
| Negative | Positive | Negative | Positive | |||
| Gender | 0.070 | 0.968 | ||||
| Male | 9 | 29 | 5 | 33 | ||
| Female | 7 | 60 | 9 | 58 | ||
| Age (year) | 0.179 | 0.310 | ||||
| ≤ 60 | 3 | 32 | 3 | 32 | ||
| > 60 | 13 | 57 | 11 | 59 | ||
| Gross type | 0.739 | 0.321 | ||||
| Invasive | 12 | 60 | 12 | 60 | ||
| Ulcerative | 0 | 2 | 0 | 2 | ||
| Polypoid | 4 | 27 | 2 | 29 | ||
| Location | 0.572 | 0.618 | ||||
| Bottom | 6 | 42 | 8 | 40 | ||
| Body | 7 | 27 | 4 | 30 | ||
| Neck | 3 | 20 | 2 | 21 | ||
| Size | 0.476 | 0.215 | ||||
| D ≤ 3.0 cm | 8 | 53 | 6 | 55 | ||
| D > 3.0 cm | 8 | 36 | 8 | 36 | ||
| Depth of invasion | 0.933 | 0.707 | ||||
| Muscular layer | 3 | 15 | 2 | 16 | ||
| Serosa | 12 | 70 | 10 | 72 | ||
| Beyond serosa | 1 | 4 | 0 | 5 | ||
| TNM stage | < 0.001 | 0.005 | ||||
| I | 5 | 4 | 4 | 5 | ||
| II | 11 | 42 | 10 | 43 | ||
| III | 0 | 10 | 0 | 10 | ||
| IV | 0 | 33 | 1 | 32 | ||
| Differentiation | < 0.001 | 0.001 | ||||
| Well | 7 | 4 | 5 | 6 | ||
| Moderate | 8 | 55 | 9 | 54 | ||
| Poor | 1 | 30 | 0 | 31 | ||
| LNM | 0.048 | 0.041 | ||||
| Yes | 0 | 18 | 0 | 18 | ||
| No | 16 | 71 | 17 | 70 | ||
| Distant metastasis | 0.001 | 0.003 | ||||
| Yes | 0 | 37 | 0 | 37 | ||
| No | 16 | 52 | 14 | 54 | ||
| Gallstone | 0.915 | 0.339 | ||||
| Yes | 2 | 12 | 3 | 11 | ||
| No | 14 | 77 | 11 | 80 | ||